Single VialHover to zoomQualified Research Reference
GHK-Cu
GHK-Cu is documented for controlled research models and literature-based evaluation only.
- Regular
- $80.00
- Elite Member−10%
- $72.00
GHK-Cu is a naturally-occurring copper-binding tripeptide supplied as a lyophilized research peptide. Prepared for controlled laboratory applications.
Studied in the context of extracellular matrix remodeling, fibroblast activity, collagen synthesis pathways, and dermal repair research.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
GHK-Cu: investigational profile.
Research Mechanism
A copper-binding tripeptide investigated for fibroblast activation, collagen and glycosaminoglycan synthesis, and metalloproteinase regulation in dermal and connective-tissue models. BPC-157 is a common comparator when extracellular-matrix turnover is the endpoint.
Investigational Profile
Isolated from human plasma by Pickart in 1973 and continuously studied since — one of the longest-running peptide research programs in the copper-peptide literature.
Research Study Window
Dermal and matrix-remodeling protocols usually run four to eight weeks so collagen turnover and fibroblast phenotype shifts can be measured directly.
Pairs With
BPC-157
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C14H24N6O4·Cu
- Molar Mass
- 402.93 g/mol
- Amino Acid Sequence
- H-Gly-His-Lys-OH (Cu²⁺ chelate)
- Synonyms
- Copper Tripeptide-1, GHK-Copper
- Solubility
- Water-soluble
- Organoleptic Profile
- Deep blue to violet powder
- Composition
- Lyophilized powder
